Search Results for: organoids

Weekly reads: CAR-T cell good news, Califf fight, stem cells on lymph

CAR-T-cell-infographic

Not everything in biomedical science is a ground-breaking discovery or clinical game-changer, but CAR-T cell technology is a combination of both. CAR-T cell good news We have such good news in this new pub on long-term benefits: Decade-long leukaemia remissions with persistence of CD4+ CAR T cells, Nature. Another recent CAR-T cell article, this one in Science, …

Weekly reads: CAR-T cell good news, Califf fight, stem cells on lymph Read More »

Recommended reads: senolytics, cow iPS cells, big CIRM royalty

Senolytics Steve Horvath

When we hear the word senile we might think stereotypically of an older person who has cognitive impairment, but some argue that senility can apply to cells too as they age and that such cells can be targeted by drugs called senolytics. Unfortunately, the supplements industry has picked up on this idea to sell iffy …

Recommended reads: senolytics, cow iPS cells, big CIRM royalty Read More »

Weekly reads: aging, CRISPR delivery, hair, oocytes, paralysis

CRISPR-Model-Jacob-Corn-e1464305007640

The big news of the week was the launch of Altos labs and their ambitious plan to tackle aging through cell therapies. Altos has recruited a large number of top cell biologists away from academia. That team plus top biotech execs and a $3B war chest make Altos one to watch in coming years. I …

Weekly reads: aging, CRISPR delivery, hair, oocytes, paralysis Read More »

Weekly science reads: senescence, alt CRISPR, sickle cell update

victoria gray family crispr sickle cell b

Is 2022 going to be any better than 2020 or 2021 when it comes to things in general or for biomedical science? Related to the pandemic? It’s too soon to say but if I had to guess right now I’d venture an optimistic view that overall it’s going to be somewhat better by the end …

Weekly science reads: senescence, alt CRISPR, sickle cell update Read More »

Weekly stem cell reads: COVID kidney, FDA letter, H3.3, EO Wilson

EO Wilson

Happy New Year and get ready for another 364 more days of stem cell excitement and craziness in 2022. In the next day or two I’ll post my predictions for this new year. Recommended reads EO Wilson obit by Carl Zimmer in NYT. Who’s the next EO Wilson or someone like him with such big impact these …

Weekly stem cell reads: COVID kidney, FDA letter, H3.3, EO Wilson Read More »

Top stem cell stories of 2021: COVID, diabetes, human embryos, clinics in court

regenerative medicine, stem cells 2021

The past year was all over the place for the stem cell and regenerative medicine field. As you can see in my scoring of my 21 predictions for 2021, quite a few things were surprises in terms of what did and didn’t happen. Here’s an overview of the top stories of the year in our …

Top stem cell stories of 2021: COVID, diabetes, human embryos, clinics in court Read More »

Weekly reads: grad student life, cell barcoding, diabetes trial, more

ViaCyte capsule stem cells diabetes

Part of being a grad student is dealing with technologies related to your projects and their limitations. Sometimes I feel old when I remember the way we used to have to do things in the lab. As a grad student, I manually poured, ran, and read giant sequencing gels. Back then, gene synthesis of a …

Weekly reads: grad student life, cell barcoding, diabetes trial, more Read More »

Recommended reads: a tale of human tails, heart reprogramming, pericytes, microglia

humans with tails

A piece on human tails and how we lost them caught my eye so I’ll start my weekly reads with that. This week I had the fewest Zoom meetings in ages, which allowed me to get more work done in my own lab and more reading. How about that? I even had some in-person meetings …

Recommended reads: a tale of human tails, heart reprogramming, pericytes, microglia Read More »

Weekly reads: vision, MyoD, liver regen, more

fish-eyes-from-stem-cells, stem cells for vision

I love stem cell research but experiments that have practical possible future applications in medicine like for vision loss are especially interesting to me. On the other hand basic research on core transcription factor mechanisms like by MyoD also really grab me. We cover some of this stuff and other ground in today’s recommended reads. …

Weekly reads: vision, MyoD, liver regen, more Read More »